| Autor: |
Rugo HS; Hope S. Rugo, MD, Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Aditya Bardia, MD, MPH, Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; and Sara M. Tolaney, MD, MPH, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bardia A; Hope S. Rugo, MD, Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Aditya Bardia, MD, MPH, Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; and Sara M. Tolaney, MD, MPH, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Tolaney SM; Hope S. Rugo, MD, Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Aditya Bardia, MD, MPH, Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; and Sara M. Tolaney, MD, MPH, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. |
